Fujian Haixi Pharmaceuticals Co., Ltd. (02637.HK) Stock Price, Chart, News and AI analysis

Q: What is the price performance of HAIXI PHARMA stock?

The current price of HAIXI PHARMA is $155.6, it has decreased 3.71% in the last trading day.

Q: What are the primary business themes or industries for Fujian Haixi Pharmaceuticals Co., Ltd.?

Fujian Haixi Pharmaceuticals Co., Ltd. belongs to Pharmaceuticals industry and the sector is Health Care

Q: What is Fujian Haixi Pharmaceuticals Co., Ltd. market cap?

Fujian Haixi Pharmaceuticals Co., Ltd.'s current market cap is $12.6B

Home

Stock

02637.HK

HAIXI PHARMA (02637.HK)

Fujian Haixi Pharmaceuticals Co., Ltd.

HK$155.6

-3.71%

$-6

CLOSED_MARKET: Jan 19, 16:00:00 HKT

Key Stats

Prev.Close

$161.5

Open

$161.6

Day's Range

$147.5 - $161.6

52 week range

$97.5 - $161.3

Volume

66.0K

Avg.Volume

140.1K

EPS (TTM)

Dividend yield

Market Cap

$12.6B

What is HAIXI PHARMA?

Fujian Haixi New Drug Creation Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Fuzhou, Fujian. The company went IPO on 2025-10-20. The Company’s main products include Anbili, Haihuitong, Ruiantuo and Saixifu. The Company’s products are mainly used in digestive system diseases, cardiovascular system diseases, endocrine system diseases, nervous system diseases, inflammatory diseases, oncology, ophthalmology, respiratory diseases and others. The firm mainly operates its businesses in the domestic market.



Features

AI Copilot for Stock & Crypto

Trading Strategies

Megabrain Investors Picks

Trading Mindshare